United States

Brian M. Thornley leads the global supply strategy from plant to patient. He oversees Merck’s digital supply chain strategy including blockchain enabled pharma, organization development and enterprise segmentation to optimize service, cost, earnings and return on capital employed. Previously, he was AVP Supply Chain Operations EMEA &amp; AP, including Planning and Strategy for Merck MSD, developing the strategic approach to deliver internal efficiencies and external transformation of the supply chain from factories to end customer. Before joining MSD he was the COO of Aegate Ltd, implementing integrated data and information networks directly with pharmacies across Europe and the first commercial pharmaceutical authentication system across the European pharmacy network. Brian provided consultancy support to the PGEU, the representative body of pharmacies in Europe.

ConV2X

Blockchain is a Team Sport

Watch the acclaimed health tech modernization symposium sessions catalyzing C-suite global market executives driving healthcare to the next plateau through initiatives, policy, trust building and low cost health solutions at **#ConV2X 2021 “Driving Telehealth & Technology: Blueprint for a New Digital Health Era”**

Focusing on health policy, telehealth and virtual care, blockchain and edge technologies, **ConV2X 2021** is the premier destination community identifying new and cost effective paths forward through real world evidence, strategy, operations, research & trends.

Enjoy the talks of healthcare leadership & breakthrough technology providers that inspire and guide informed decision making for health policy development, health systems and world citizens to successfully navigate a new digital health era.

Focusing on health policy, telehealth and virtual care, blockchain and edge technologies, ConV2X 2021 is the premier destination community identifying new and cost effective paths forward through real world evidence, strategy, operations, research & trends.

Brian M. Thornley leads the global supply strategy from plant to patient. He oversees Merck’s digital supply chain strategy including blockchain enabled pharma, organization development and enterprise segmentation to optimize service, cost, earnings and return on capital employed. Previously, he was AVP Supply Chain Operations EMEA & AP, including Planning and Strategy for Merck MSD, developing the strategic approach to deliver internal efficiencies and external transformation of the supply chain from factories to end customer. Before joining MSD he was the COO of Aegate Ltd, implementing integrated data and information networks directly with pharmacies across Europe and the first commercial pharmaceutical authentication system across the European pharmacy network. Brian provided consultancy support to the PGEU, the representative body of pharmacies in Europe.

keynote

Panel experts will discuss understanding what accessible “patient-centered” mRPM entails from both a clinical and technology perspective, outline current challenges impacting innovation and trust in the use of mRPM from regulatory, physician and patient perspectives and detail benefits and gaps in making mRPM accessible for all patients.

The Future of Patient-Centered mRPM

Expect to disrupt traditional buyer models of bygone policies and data access with these panelists. Consuming information and social services are now decentralized in a collaborative ecosystem. What are the obstacles to privacy policy and should we have a national focus similar to GDPR? Privacy, security and trust must meet a minimum standard set by the government. What about the digital divide? Are policy maker debates too funding focused? Learn more about consumers and the new data economy on this panel.

Consumer Loyalty in the New Health Data Economy: Fair Data Strategies, Innovation, Trust & Trends

Panelists discuss how telehealth advances increased access, quality of care and metrics to inform enhancements to care delivery in the US. In addition, discussion will include developing strategic partnerships along the continuum of care delivery to increase cost reductions, improved access and improved patient engagement.

Successes and Failures: Gaps in Home Health Care

This discussion will bridge digital divides deploying telehealth services and care in everyday environments including laundromats and libraries bringing those behand, beside. What are the challenges and outcomes for low income communities with no Wi-Fi, laptops or stable internet? Panelists will share solutions to launch in communities with cost effective telehealth solutions.

Driving Telehealth Equity through Local Libraries & Community Connectivity

What is the value proposition for this emerging market? Obtain a bird’s eye view of VC and inventor perspective on the home health movement. This is where new PE & Venture money is moving – in home based tech and care. Panelists will discuss the reimbursement map, integration into workflow and getting provider to change the way they do business.

Home Health and the Future

Panel experts will discuss understanding what accessible “patient-centered” mRPM entails from both a clinical and technology perspective, outline current challenges impacting innovation and trust in the use of mRPM from regulatory, physician and patient perspectives and detail benefits and gaps in making mRPM accessible for all patients.


Musculoskeletal disorders effect one in every two Americans costing $213 billion a year as the #1 cause of disability worldwide, with cost and disability rates of musculoskeletal disorders (MSDs) continues to escalate. Speakers will discuss new ways to reduce this workforce epidemic through cost effective physical therapy (PT) and virtual care from employer and employee perspectives.

Efficiency & Outcomes of Direct Access to Physical Therapy for Musculoskeletal Disorders vs Physician-First Access in the US

Viewers will gain a deep understanding of school setting and challenges schools can meet medical needs. Topics will include FERPA and HIPAA rules and regulations, proper consent for medical care in schools, understanding how enrollment and engagement affects access, reimbursement challenges and engagement with local resources and primary care clinics to identify gaps in care.

Meeting Needs of Pediatric Patients in Grades K-12 with Telehealth: A Case Study

Strong telehealth governance serves as the cornerstone for advancing a telehealth strategy by ensuring that the health system has the intentional leadership infrastructure to compete and excel in this fast-paced and transforming industry. 

Effective governance is the essential first step towards successful management. The former informs the latter to optimize value to the stakeholders. Paraphrasing the Financial Reporting Council, corporate (telehealth) governance should contribute to better company performance by helping a board discharge its duties in the best interests of stakeholders: executive leadership, management, staff, customers, patients, vendors, communities, and regulators, etc. Good governance facilitates efficient, effective, and entrepreneurial management that can deliver value over the longer term. If ignored, the consequences may be vulnerability or poor performance (Financial Reporting Council, 2008).

Financial Confidence Strategies for Telehealth ROI & Investment Value

The session will include obstacles and constraints in technology infrastructure, patient habit and payment models, regulations that encourage adoption of telehealth, the unprecedented imperatives of COVID, access to rural populations and the health conditions addressed. In addition, viewers will glean new market opportunities to capture through telehealth partnerships and scale.

Premium content

Blockchain is a Team Sport

Downloads

Next from ConV2X

The Future of Patient-Centered mRPM

Similar lecture

Hospitals Without Walls

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES